Download SmartTRAK's Interview Transcript
Nnamdi Njoku, Medtronic’s Senior Vice President and President Neuromodulation, and Charlie Covert, Vice President and General Manager of Pain Therapies, discuss what’s new for Medtronic Neuromodulation, expected market growth in 2023 and strategies for driving growth in spinal cord stimulation (SCS) and deep brain stimulation (DBS) in an interview with SmartTRAK. To find out more about the Company’s latest innovations, expanding indications and what’s next for Medtronic Neuromodulation, read our article!
